Order results by:
Issue | Title | |
Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
"... and the availability of effective medical care. The current approach of access to cancer medicines limits ..." | ||
Vol 17, No 3 (2024) | Approaches to developing mechanisms for medical care centralization at the interterritorial level | Abstract similar documents |
D. V. Fedyaev, F. S. Nikitin, S. A. Kovaleva, V. V. Omelyanovskiy | ||
"... levels of hospitalizations in order to determine the need for centralization or the creation ..." | ||
Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
"... Модель финансирования медицинской помощи по клинико-статистическим группам (КСГ) в 2018 г ..." | ||
Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract similar documents |
M. A. Shapovalova, L. R. Koretskaya | ||
"... of pharmacotherapy and medical services in the department of neurology. An assessment of the costs of hospitalization ..." | ||
Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
"... ) and International Medicine Reference Piece Data. The data array was based on the fiscal data provided by pharmacies ..." | ||
Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract similar documents |
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
"... стационарном этапах оказания медицинской помощи. Затраты на лекарственную терапию определены согласно режимам ..." | ||
Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
"... regimens with centralized purchases and the cost of targeted drugs per hospitalization case were calculated ..." | ||
Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
"... of medicines in different countries and systems of healthcare. Material and methods. Based on the open-access ..." | ||
Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
"... ; the state register of manufacturers' maximum selling prices for medicines included in the list of vital ..." | ||
Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
M. V. Sura | ||
"... of medicines to treat rare diseases, in accordance with the list of rare (orphan) diseases, the list ..." | ||
Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
"... The purpose of our research was to analyze the actual practice of medicine in patients with breast ..." | ||
Vol 18, No 2 (2025) | Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 | Abstract similar documents |
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina | ||
"... and orphan ones) requiring essential treatment, particularly expensive medicines. At the same time ..." | ||
Vol 17, No 4 (2024) | Standardized methodology for calculating the cost of medical care funded by government sources | Abstract similar documents |
M. A. Sdvizhkova, S. A. Kovaleva, D. V. Fedyaev, V. V. Omelyanovskiy | ||
"... рост потребностей в медицинской помощи (МП), усиливают давление на ограниченные ресурсы системы ..." | ||
Vol 9, No 3 (2016) | MONITORING OF CONSUMER ATTITUDES TO MEDICINES | Abstract similar documents |
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
"... Objective. Comparative analysis and monitoring of the population’s attitude to medicines through ..." | ||
Vol 17, No 1 (2024) | STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia | Abstract similar documents |
A. V. Zhuravlev, O. I. Knysh | ||
"... of Health of the RF, regulatory framework of the RF, data from the State Register of Medicines of the RF ..." | ||
Vol 8, No 4 (2015) | PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS | Abstract similar documents |
M. V. Sura | ||
"... in hospital conditions), but also its measurement units (transition from bed days to hospitalization cases ..." | ||
Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract similar documents |
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
"... лекарственных препаратов в статье изучены технологические, организационные, регуляторные требования по вопросам ..." | ||
Vol 9, No 2 (2016) | GENDER FEATURES OF THE POPULATION'S ATTITUDE TO MEDICINES | Abstract similar documents |
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
"... Objective. The study of gender features of attitudes visitors of pharmacies to medicines ..." | ||
Vol 13, No 4 (2020) | Concept of value-based healthcare | Abstract similar documents |
N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov | ||
"... контроле и оплате медицинской помощи оценка результатов лечения осуществляется выборочно и на отдельных ..." | ||
Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
J. A. Agafonova, V. V. Omelyanovskiy | ||
"... analyzed medical care provided in inpatient and day hospital settings using depersonalized hospitalization ..." | ||
Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
"... Territory are the least concentrated. The main burden of providing socially significant types of medicines ..." | ||
Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
"... лекарственной помощи пациентов с данными заболеваниями в условиях стационара. Проведена статистическая обработка ..." | ||
Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
"... году и особенности оплаты онкологической помощи, с описанием практики использования схем лекарственной ..." | ||
Vol 5, No 2 (2012) | MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS | Abstract similar documents |
Yu. V. Miroshnichenko, V. S. Gaynov | ||
"... , устанавливающего норму снабжения лекарственными препаратами и материалами для терапевтической стоматологии ..." | ||
Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
"... Objective: to analyse of medicines prescriptions for federal beneficiaries with circulatory system ..." | ||
Vol 11, No 2 (2018) | Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review | Abstract similar documents |
T. P. Bezdenezhnykh, D. V. Lukyantseva | ||
"... Departmental medicine as a Russian-specific healthcare system is currently subject to broad ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... of hospitalization were calculated and compared with the imposed tariffs. For the evaluation of the possibility ..." | ||
Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract similar documents |
V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
"... in veterinary medicine. This will solve the problem of pharmacotherapy availability and allow veterinarians ..." | ||
Vol 9, No 2 (2016) | EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL | Abstract similar documents |
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova | ||
"... -acquires pneumonia passing hospitalization in pulmonology department and department of intensive care ..." | ||
Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
"... databases, a search was made for clinical and economic studies of medicines included in the HCN list ..." | ||
Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
"... and Essential Medicines, List of Medical Drugs for Certain Categories of Citizens, List of High-Cost Medical ..." | ||
Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... Цель. Анализ методов государственного регулирования цен производителей лекарственных препаратов в ..." | ||
Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs ..." | ||
Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... стандартов медицинской помощи, а также для уточнения вопросов лекарственной терапии пациентов с РЗ ..." | ||
Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
"... В статье рассматривается международный опыт лекарственного обращения и те риски, с которыми ..." | ||
Vol 17, No 4 (2024) | Scenario modeling of the drug prescription process for children: application of machine learning methods | Abstract similar documents |
А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova | ||
"... лекарственных препаратов (ЛП) детям в условиях медицинской организации, оценка его производительности и ..." | ||
Vol 13, No 3 (2020) | Regulatory framework of the oncological medical care provision | Abstract similar documents |
S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy | ||
"... of the Government of the Russian Federation regulating the provision of medicines and medical products, provisions ..." | ||
Vol 11, No 4 (2018) | Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense | Abstract similar documents |
D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy | ||
"... помощи в рамках ведомственной медицины. Приведен обзор ведомственного законодательства Министерства ..." | ||
Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
"... закупке лекарственных препаратов, применяемых для терапии редких заболеваний в 2013 г. В работе ..." | ||
Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract similar documents |
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
"... нерациональному расходованию бюджетных средств на лекарственное обеспечение. В данной статье предложена концепция ..." | ||
Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
"... Objective: to study the characteristics of the population consumption of medicines ..." | ||
Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract similar documents |
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
"... лекарственной помощи, в соответствии с ФЗ №178-ФЗ от 17.07.1999, все большая нагрузка по лекарственному ..." | ||
Vol 18, No 2 (2025) | Marketing analysis of the Russian pharmaceutical market for treatment of neovascular age-related macular degeneration | Abstract similar documents |
F. V. Gorkavenko, A. B. Goryachev, O. V. Ashikhmina, D. V. Fedyaev, N. V. Ignateva, E. A. Smolyarchuk, A. V. Kirchenko, D. D. Tkachenko, V. I. Brazhnikova | ||
"... in procurement volumes in physical terms and in the number of hospitalizations involving the use of these drugs ..." | ||
Vol 13, No 3 (2020) | Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up | Abstract similar documents |
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko | ||
"... , disability, social status) and clinical-economic data (diagnoses, duration of hospitalization), information ..." | ||
Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
"... помощи, обычно собираемые из различных источников в рамках исследований реальной клинической практики ..." | ||
Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
"... Цель: фармакоэпидемиологический анализ номенклатуры лекарственных препаратов (ЛП), используемых в ..." | ||
Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract similar documents |
V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
"... is coordinated at the federal level in agreement with the principles of evidence-based medicine ..." | ||
Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
"... – изготовления лекарственных препаратов (ЛП) аптечными организациями – в обзоре обобщены технологические ..." | ||
Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
"... in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD ..." | ||
Vol 10, No 2 (2017) | THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS | Abstract similar documents |
V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko | ||
"... Among the most important aspects of the health policy are the methods for pricing of medicines ..." | ||
1 - 50 of 315 Items | 1 2 3 4 5 6 7 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)